Cargando…

Circulating Tumor Cell Is a Clinical Indicator of Pretransplant Radiofrequency Ablation for Patients with Hepatocellular Carcinoma

INTRODUCTION: It is of great significance to confirm reliable indicators for the guidance of pretransplant radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). In this study, we aim to investigate whether circulating tumor cell (CTC) status is a clinical indicator for RFA before liver t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhitao, Wang, Tielong, Chen, Chuanbao, Hong, Xitao, Yu, Jia, Ma, Yihao, Guo, Yiwen, Huang, Changjun, He, Xiaoshun, Ju, Weiqiang, Chen, Maogen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548160/ https://www.ncbi.nlm.nih.gov/pubmed/34712326 http://dx.doi.org/10.1155/2021/7776389

Ejemplares similares

Transplantation of Extended Criteria Donor Livers Following Continuous Normothermic Machine Perfusion Without Recooling
por: Chen, Zhitao, et al.
Publicado: (2022)

Utilization of hepatitis B surface antigen-positive donors in liver transplantation for recipients with hepatocellular carcinoma: a retrospective and propensity score matching analysis
por: Chen, Zhitao, et al.
Publicado: (2023)

Application of various surgical techniques in liver transplantation: a retrospective study
por: Chen, Zhitao, et al.
Publicado: (2021)

Continuous Normothermic Machine Perfusion for Renovation of Extended Criteria Donor Livers Without Recooling in Liver Transplantation: A Pilot Experience
por: Chen, Zhitao, et al.
Publicado: (2021)

Application of ischaemia‐free liver transplantation improves prognosis of patients with steatotic donor livers – a retrospective study
por: Chen, Maogen, et al.
Publicado: (2021)

En bloc procurement of porcine abdominal multiple organ block for ex situ normothermic machine perfusion: a technique for avoiding initial cold preservation
por: Chen, Chuanbao, et al.
Publicado: (2021)

A marginal liver graft with hyperbilirubinemia transplanted successfully by ischemia-free liver transplantation
por: Huang, Changjun, et al.
Publicado: (2021)

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Uremia, and Insulin-Dependent Diabetes
por: Hong, Xitao, et al.
Publicado: (2022)

Analysis of preoperative circulating tumor cells for recurrence in patients with hepatocellular carcinoma after liver transplantation
por: Chen, Zhitao, et al.
Publicado: (2020)

Ischemic-Free Liver Transplantation Reduces the Recurrence of Hepatocellular Carcinoma After Liver Transplantation
por: Tang, Yunhua, et al.
Publicado: (2021)

Neoadjuvant programmed cell death 1 inhibitor before liver transplantation for HCC is not associated with increased graft loss
por: Wang, Tielong, et al.
Publicado: (2023)

Novel ceRNA network construction associated with programmed cell death in acute rejection of heart allograft in mice
por: Guo, Yiwen, et al.
Publicado: (2023)

Non-re-cooling implantation of marginal liver graft after machine perfusion: report of a case
por: Ju, Weiqiang, et al.
Publicado: (2020)

DTYMK Expression Predicts Prognosis and Chemotherapeutic Response and Correlates with Immune Infiltration in Hepatocellular Carcinoma
por: Guo, Yiwen, et al.
Publicado: (2021)

Prevalence and clinical significance of regional lymphadenectomy in patients with hepatocellular carcinoma
por: Yang, Anli, et al.
Publicado: (2019)

lncRNA XIST regulates proliferation and migration of hepatocellular carcinoma cells by acting as miR-497-5p molecular sponge and targeting PDCD4
por: Zhang, Yixi, et al.
Publicado: (2019)

Left branch of portal vein thrombosis in a liver transplant recipient with donation after cardiac death donor: A case report
por: Chen, Maogen, et al.
Publicado: (2016)

First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People’s Republic of China: 5-year Experience at a High-volume Donor and Recipient Liver Transplant Center
por: Chen, Zhitao, et al.
Publicado: (2023)

An Alternative Surgical Technique of Native Hepatectomy in Liver Transplantation
por: Chen, Maogen, et al.
Publicado: (2021)

Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma
por: Kwak, Min Hwan, et al.
Publicado: (2022)

Radiofrequency Thermal Ablation of Hepatocellular Carcinomas
por: Lim, Hyo Keun
Publicado: (2000)

Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis
por: Kim, Ha Il, et al.
Publicado: (2023)

The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma
por: Xu, Zhentian, et al.
Publicado: (2019)

Severe sclerosing cholangitis after Langerhans cell histiocytosis treated by liver transplantation: An adult case report
por: Tang, Yunhua, et al.
Publicado: (2017)

Use of radiofrequency ablation in the treatment of hepatocellular carcinoma: Experience of ablation protocols
por: MASAYOSHI, TAKAHASHI, et al.
Publicado: (2012)

Radiofrequency Ablation of Hepatocellular Carcinoma: A Literature Review
por: Minami, Yasunori, et al.
Publicado: (2011)

Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma
por: Himoto, Takashi, et al.
Publicado: (2012)

An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation
por: Guo, Yusheng, et al.
Publicado: (2022)

Surgical Resection or Radiofrequency Ablation for Small Hepatocellular Carcinoma
por: Feng, Qingbo, et al.
Publicado: (2022)

Surgical Resection or Radiofrequency Ablation for Small Hepatocellular Carcinoma
por: Kawaguchi, Yoshikuni, et al.
Publicado: (2023)

Role of Pretransplant Treatments for Patients with Hepatocellular Carcinoma Waiting for Liver Transplantation
por: Ogawa, Kohei, et al.
Publicado: (2022)

Progression of hepatocellular carcinoma after radiofrequency ablation: Current status of research
por: Wu, Shilun, et al.
Publicado: (2022)

Therapeutic Efficacy of Percutaneous Radiofrequency Ablation versus Microwave Ablation for Hepatocellular Carcinoma
por: Zhang, Lei, et al.
Publicado: (2013)

Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma
por: Xu, Yun, et al.
Publicado: (2017)

Recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: Analysis of the pattern and risk factors
por: Chen, Rui, et al.
Publicado: (2023)

Systematic analysis on multiple Gene Expression Omnibus data sets reveals fierce immune response in hepatitis B virus‐related acute liver failure
por: Chen, Huadi, et al.
Publicado: (2020)

Long-term outcomes of combined radiofrequency ablation and multipronged ethanol ablation for the treatment of unfavorable hepatocellular carcinoma
por: Liu, Ming, et al.
Publicado: (2023)

Combined Transarterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Infeasible for Ultrasound-Guided Percutaneous Radiofrequency Ablation: A Comparative Study with General Ultrasound-Guided Radiofrequency Ablation Outcomes
por: Cha, Dong Ik, et al.
Publicado: (2023)

Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation
por: Chen, Jinbin, et al.
Publicado: (2018)

Bronchobiliary fistula after radiofrequency ablation for hepatocellular carcinoma successfully treated by double drainage
por: Chang, Yi Chen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c7qm7e4e7v9a5qlol6ujrgtmpm